Artal Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Artal Group’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-48,000	Closed	-$292K	–	148
2022 Q4	$292K	Hold	48,000	–	–	0.02%	121
2022 Q3	$666K	Hold	48,000	–	–	0.03%	122
2022 Q2	$1.93M	Hold	48,000	–	–	0.1%	97
2022 Q1	$5.05M	Hold	48,000	–	–	0.21%	77
2021 Q4	$5.53M	Hold	48,000	–	–	0.15%	98
2021 Q3	$18.2M	Hold	48,000	–	–	0.41%	58
2021 Q2	$19.6M	Hold	48,000	–	–	0.4%	56
2021 Q1	$22.9M	Buy	+48,000	New	+$26.1M	0.4%	55

Other funds holding NEXI

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Allen Operations New York $722M AUM 20.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Artal Group's NEXI Position: Q1 2023 in Review

Artal Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2023, closing a stake of 48,000 shares — an estimated $292K sold.

Artal Group first reported a position in NEXI in Q1 2021 and held it in 8 quarters. The position peaked at $22.9M in Q1 2021. 31 funds tracked by Wall St. Rank hold NEXI as of Q1 2023.

Artal Group reported no remaining NexImmune, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Artal Group sold 48,000 NexImmune, Inc. Common Stock shares in Q1 2023, an estimated $292K.
Artal Group first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Artal Group's NexImmune, Inc. Common Stock position peaked at $22.9M in Q1 2021.
31 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.